nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—Back pain—Vincristine—muscle cancer	0.00401	0.00401	CcSEcCtD
Valaciclovir—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.00398	0.00398	CcSEcCtD
Valaciclovir—Myalgia—Dactinomycin—muscle cancer	0.00395	0.00395	CcSEcCtD
Valaciclovir—Anaemia—Vincristine—muscle cancer	0.00383	0.00383	CcSEcCtD
Valaciclovir—Urinary tract disorder—Etoposide—muscle cancer	0.00381	0.00381	CcSEcCtD
Valaciclovir—Agitation—Vincristine—muscle cancer	0.00381	0.00381	CcSEcCtD
Valaciclovir—Photosensitivity—Methotrexate—muscle cancer	0.0038	0.0038	CcSEcCtD
Valaciclovir—Oedema—Dactinomycin—muscle cancer	0.00378	0.00378	CcSEcCtD
Valaciclovir—Urethral disorder—Etoposide—muscle cancer	0.00378	0.00378	CcSEcCtD
Valaciclovir—Infection—Dactinomycin—muscle cancer	0.00376	0.00376	CcSEcCtD
Valaciclovir—Aplastic anaemia—Doxorubicin—muscle cancer	0.00374	0.00374	CcSEcCtD
Valaciclovir—Leukopenia—Vincristine—muscle cancer	0.00371	0.00371	CcSEcCtD
Valaciclovir—Thrombocytopenia—Dactinomycin—muscle cancer	0.00371	0.00371	CcSEcCtD
Valaciclovir—Erythema multiforme—Etoposide—muscle cancer	0.00365	0.00365	CcSEcCtD
Valaciclovir—Coma—Doxorubicin—muscle cancer	0.00364	0.00364	CcSEcCtD
Valaciclovir—Renal failure acute—Methotrexate—muscle cancer	0.00362	0.00362	CcSEcCtD
Valaciclovir—Anorexia—Dactinomycin—muscle cancer	0.00361	0.00361	CcSEcCtD
Valaciclovir—Mouth ulceration—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Valaciclovir—Convulsion—Vincristine—muscle cancer	0.00359	0.00359	CcSEcCtD
Valaciclovir—Hypertension—Vincristine—muscle cancer	0.00358	0.00358	CcSEcCtD
Valaciclovir—Myalgia—Vincristine—muscle cancer	0.00353	0.00353	CcSEcCtD
Valaciclovir—Immune system disorder—Etoposide—muscle cancer	0.00348	0.00348	CcSEcCtD
Valaciclovir—Mediastinal disorder—Etoposide—muscle cancer	0.00347	0.00347	CcSEcCtD
Valaciclovir—Chills—Etoposide—muscle cancer	0.00346	0.00346	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00345	0.00345	CcSEcCtD
Valaciclovir—Alopecia—Etoposide—muscle cancer	0.00341	0.00341	CcSEcCtD
Valaciclovir—Anaphylactic shock—Vincristine—muscle cancer	0.00338	0.00338	CcSEcCtD
Valaciclovir—Oedema—Vincristine—muscle cancer	0.00338	0.00338	CcSEcCtD
Valaciclovir—Infection—Vincristine—muscle cancer	0.00336	0.00336	CcSEcCtD
Valaciclovir—Osteoarthritis—Methotrexate—muscle cancer	0.00334	0.00334	CcSEcCtD
Valaciclovir—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00332	0.00332	CcSEcCtD
Valaciclovir—Nervous system disorder—Vincristine—muscle cancer	0.00332	0.00332	CcSEcCtD
Valaciclovir—Thrombocytopenia—Vincristine—muscle cancer	0.00331	0.00331	CcSEcCtD
Valaciclovir—Photosensitivity—Doxorubicin—muscle cancer	0.00329	0.00329	CcSEcCtD
Valaciclovir—Decreased appetite—Dactinomycin—muscle cancer	0.00329	0.00329	CcSEcCtD
Valaciclovir—Fatigue—Dactinomycin—muscle cancer	0.00326	0.00326	CcSEcCtD
Valaciclovir—Back pain—Etoposide—muscle cancer	0.00325	0.00325	CcSEcCtD
Valaciclovir—Pain—Dactinomycin—muscle cancer	0.00324	0.00324	CcSEcCtD
Valaciclovir—Anorexia—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Valaciclovir—Eczema—Doxorubicin—muscle cancer	0.00322	0.00322	CcSEcCtD
Valaciclovir—Ataxia—Methotrexate—muscle cancer	0.00314	0.00314	CcSEcCtD
Valaciclovir—Renal failure acute—Doxorubicin—muscle cancer	0.00313	0.00313	CcSEcCtD
Valaciclovir—Feeling abnormal—Dactinomycin—muscle cancer	0.00312	0.00312	CcSEcCtD
Valaciclovir—Anaemia—Etoposide—muscle cancer	0.0031	0.0031	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00309	0.00309	CcSEcCtD
Valaciclovir—Liver function test abnormal—Methotrexate—muscle cancer	0.00308	0.00308	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00308	0.00308	CcSEcCtD
Valaciclovir—Insomnia—Vincristine—muscle cancer	0.00306	0.00306	CcSEcCtD
Valaciclovir—Renal impairment—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Valaciclovir—Paraesthesia—Vincristine—muscle cancer	0.00304	0.00304	CcSEcCtD
Valaciclovir—Leukopenia—Etoposide—muscle cancer	0.003	0.003	CcSEcCtD
Valaciclovir—Abdominal pain—Dactinomycin—muscle cancer	0.00299	0.00299	CcSEcCtD
Valaciclovir—Body temperature increased—Dactinomycin—muscle cancer	0.00299	0.00299	CcSEcCtD
Valaciclovir—Decreased appetite—Vincristine—muscle cancer	0.00294	0.00294	CcSEcCtD
Valaciclovir—Cough—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Vincristine—muscle cancer	0.00292	0.00292	CcSEcCtD
Valaciclovir—Fatigue—Vincristine—muscle cancer	0.00292	0.00292	CcSEcCtD
Valaciclovir—Convulsion—Etoposide—muscle cancer	0.00291	0.00291	CcSEcCtD
Valaciclovir—Hypertension—Etoposide—muscle cancer	0.0029	0.0029	CcSEcCtD
Valaciclovir—Constipation—Vincristine—muscle cancer	0.00289	0.00289	CcSEcCtD
Valaciclovir—Pain—Vincristine—muscle cancer	0.00289	0.00289	CcSEcCtD
Valaciclovir—Osteoarthritis—Doxorubicin—muscle cancer	0.00289	0.00289	CcSEcCtD
Valaciclovir—Chest pain—Etoposide—muscle cancer	0.00286	0.00286	CcSEcCtD
Valaciclovir—Migraine—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00284	0.00284	CcSEcCtD
Valaciclovir—Face oedema—Doxorubicin—muscle cancer	0.00279	0.00279	CcSEcCtD
Valaciclovir—Hypersensitivity—Dactinomycin—muscle cancer	0.00279	0.00279	CcSEcCtD
Valaciclovir—Abdominal discomfort—Methotrexate—muscle cancer	0.00277	0.00277	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Vincristine—muscle cancer	0.00276	0.00276	CcSEcCtD
Valaciclovir—Confusional state—Etoposide—muscle cancer	0.00276	0.00276	CcSEcCtD
Valaciclovir—Anaphylactic shock—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Valaciclovir—Infection—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Valaciclovir—Ataxia—Doxorubicin—muscle cancer	0.00272	0.00272	CcSEcCtD
Valaciclovir—Asthenia—Dactinomycin—muscle cancer	0.00272	0.00272	CcSEcCtD
Valaciclovir—Blood creatinine increased—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Valaciclovir—Dehydration—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Valaciclovir—Thrombocytopenia—Etoposide—muscle cancer	0.00268	0.00268	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00268	0.00268	CcSEcCtD
Valaciclovir—Tachycardia—Etoposide—muscle cancer	0.00267	0.00267	CcSEcCtD
Valaciclovir—Abdominal pain—Vincristine—muscle cancer	0.00267	0.00267	CcSEcCtD
Valaciclovir—Body temperature increased—Vincristine—muscle cancer	0.00267	0.00267	CcSEcCtD
Valaciclovir—Liver function test abnormal—Doxorubicin—muscle cancer	0.00267	0.00267	CcSEcCtD
Valaciclovir—Skin disorder—Etoposide—muscle cancer	0.00266	0.00266	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Methotrexate—muscle cancer	0.00263	0.00263	CcSEcCtD
Valaciclovir—Anorexia—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Valaciclovir—Diarrhoea—Dactinomycin—muscle cancer	0.00259	0.00259	CcSEcCtD
Valaciclovir—Nasopharyngitis—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Valaciclovir—Depression—Methotrexate—muscle cancer	0.00256	0.00256	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00255	0.00255	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—muscle cancer	0.00253	0.00253	CcSEcCtD
Valaciclovir—Stomatitis—Methotrexate—muscle cancer	0.00251	0.00251	CcSEcCtD
Valaciclovir—Influenza—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Valaciclovir—Hypersensitivity—Vincristine—muscle cancer	0.00249	0.00249	CcSEcCtD
Valaciclovir—Paraesthesia—Etoposide—muscle cancer	0.00246	0.00246	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Valaciclovir—Dyspnoea—Etoposide—muscle cancer	0.00244	0.00244	CcSEcCtD
Valaciclovir—Somnolence—Etoposide—muscle cancer	0.00243	0.00243	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—muscle cancer	0.00243	0.00243	CcSEcCtD
Valaciclovir—Asthenia—Vincristine—muscle cancer	0.00243	0.00243	CcSEcCtD
Valaciclovir—Vomiting—Dactinomycin—muscle cancer	0.00241	0.00241	CcSEcCtD
Valaciclovir—Bronchitis—Doxorubicin—muscle cancer	0.0024	0.0024	CcSEcCtD
Valaciclovir—Rash—Dactinomycin—muscle cancer	0.00239	0.00239	CcSEcCtD
Valaciclovir—Decreased appetite—Etoposide—muscle cancer	0.00238	0.00238	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Valaciclovir—Fatigue—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Valaciclovir—Constipation—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Valaciclovir—Pain—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00232	0.00232	CcSEcCtD
Valaciclovir—Diarrhoea—Vincristine—muscle cancer	0.00231	0.00231	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—muscle cancer	0.00229	0.00229	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00228	0.00228	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Valaciclovir—Feeling abnormal—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Valaciclovir—Nausea—Dactinomycin—muscle cancer	0.00225	0.00225	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Etoposide—muscle cancer	0.00224	0.00224	CcSEcCtD
Valaciclovir—Dizziness—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Valaciclovir—Renal failure—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Valaciclovir—Urticaria—Etoposide—muscle cancer	0.00218	0.00218	CcSEcCtD
Valaciclovir—Stomatitis—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Valaciclovir—Abdominal pain—Etoposide—muscle cancer	0.00217	0.00217	CcSEcCtD
Valaciclovir—Body temperature increased—Etoposide—muscle cancer	0.00217	0.00217	CcSEcCtD
Valaciclovir—Urinary tract infection—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Valaciclovir—Vomiting—Vincristine—muscle cancer	0.00215	0.00215	CcSEcCtD
Valaciclovir—Rash—Vincristine—muscle cancer	0.00213	0.00213	CcSEcCtD
Valaciclovir—Dermatitis—Vincristine—muscle cancer	0.00213	0.00213	CcSEcCtD
Valaciclovir—Haematuria—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Valaciclovir—Headache—Vincristine—muscle cancer	0.00212	0.00212	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—muscle cancer	0.00208	0.00208	CcSEcCtD
Valaciclovir—Chills—Methotrexate—muscle cancer	0.00207	0.00207	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—muscle cancer	0.00204	0.00204	CcSEcCtD
Valaciclovir—Hypersensitivity—Etoposide—muscle cancer	0.00202	0.00202	CcSEcCtD
Valaciclovir—Nausea—Vincristine—muscle cancer	0.00201	0.00201	CcSEcCtD
Valaciclovir—Rhinitis—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Valaciclovir—Asthenia—Etoposide—muscle cancer	0.00197	0.00197	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Valaciclovir—Pruritus—Etoposide—muscle cancer	0.00194	0.00194	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Valaciclovir—Diarrhoea—Etoposide—muscle cancer	0.00187	0.00187	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—muscle cancer	0.00186	0.00186	CcSEcCtD
Valaciclovir—Dizziness—Etoposide—muscle cancer	0.00181	0.00181	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—muscle cancer	0.00177	0.00177	CcSEcCtD
Valaciclovir—Cough—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—muscle cancer	0.00174	0.00174	CcSEcCtD
Valaciclovir—Vomiting—Etoposide—muscle cancer	0.00174	0.00174	CcSEcCtD
Valaciclovir—Rash—Etoposide—muscle cancer	0.00173	0.00173	CcSEcCtD
Valaciclovir—Dermatitis—Etoposide—muscle cancer	0.00173	0.00173	CcSEcCtD
Valaciclovir—Headache—Etoposide—muscle cancer	0.00172	0.00172	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Valaciclovir—Confusional state—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Valaciclovir—Infection—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Valaciclovir—Nausea—Etoposide—muscle cancer	0.00163	0.00163	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—muscle cancer	0.00159	0.00159	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Valaciclovir—Convulsion—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—muscle cancer	0.00144	0.00144	CcSEcCtD
Valaciclovir—Confusional state—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Valaciclovir—Pain—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—muscle cancer	0.00134	0.00134	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Valaciclovir—Insomnia—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Valaciclovir—Dyspnoea—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Valaciclovir—Decreased appetite—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Valaciclovir—Feeling abnormal—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Valaciclovir—Body temperature increased—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—muscle cancer	0.00112	0.00112	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Valaciclovir—Hypersensitivity—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Valaciclovir—Rash—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Valaciclovir—Headache—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Valaciclovir—Asthenia—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Valaciclovir—Pruritus—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—muscle cancer	0.000975	0.000975	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—muscle cancer	0.000972	0.000972	CcSEcCtD
Valaciclovir—Dizziness—Doxorubicin—muscle cancer	0.000939	0.000939	CcSEcCtD
Valaciclovir—Vomiting—Doxorubicin—muscle cancer	0.000903	0.000903	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—muscle cancer	0.000896	0.000896	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—muscle cancer	0.000895	0.000895	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—muscle cancer	0.00089	0.00089	CcSEcCtD
Valaciclovir—Nausea—Doxorubicin—muscle cancer	0.000844	0.000844	CcSEcCtD
